The Palantir controversy escalated in 2019. Activists and human rights organizations criticized the company's contracts with ...
Poseida Therapeutics stock skyrocketed Tuesday after Roche closed a deal to acquire the California-based biopharmaceutical ...
Wood's firm makes a move on two of the biggest names in the tech sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback